BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Rodin Therapeutics

Rodin Therapeutics logo

Founded
2013
Geography
United States of America based
Funding
$57.200 M

Rodin Therapeutics, a biotechnology company applying insights of epigenetics to novel therapeutics for neurological disorders, announced its founding by Atlas Venture and Proteros biostructures. Rodin is founded based on its insight into key epigenetic modulators of CNS function, privileged access to Proteros' best-in-class structural biology capabilities, and a team with deep CNS drug development and company formation experience. Rodin secured financing from Atlas Venture and Johnson & Johnson Development Corporation (JJDC).

Technologies

Epigenetics Startups  

R&D Platform


Pipelines

No pipelines published yet

Products

 

Services

No services posted yet